Inventor · disambiguated record
Ricardo Alberto Vargas Rincon
Also filed as: VARGAS RINCON RICARDO ALBERTO
15 granted patents·4 pending applications·37 citations·filing 2011–2023
91Inventor score
Top patents by PatentIndex Score
19 records- 0196US10111839B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA·Filed 2018·Granted Oct 30, 2018·12 cites·28 claims
- 0295US10292939B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2018·Granted May 21, 2019·7 cites·8 claims
- 0393US9974752B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA·Filed 2015·Granted May 22, 2018·11 cites·30 claims
- 0491US10449159B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Oct 22, 2019·2 cites·28 claims
- 0589US2024245616A1Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2023·Application pending·0 cites
- 0687US10292938B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2018·Granted May 21, 2019·1 cites·29 claims
- 0782US11896722B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2022·Granted Feb 13, 2024·0 cites·15 claims
- 0882US10688060B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Jun 23, 2020·1 cites·14 claims
- 0981US10512612B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Dec 24, 2019·1 cites·30 claims
- 1079US10568841B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Feb 25, 2020·0 cites·8 claims
- 1177US10507186B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Dec 17, 2019·0 cites·30 claims
- 1276US10500162B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2018·Granted Dec 10, 2019·0 cites·28 claims
- 1373US2020306200A1Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2020·Application pending·0 cites
- 1472US10512613B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA LP·Filed 2019·Granted Dec 24, 2019·0 cites·30 claims
- 1570US9814710B2Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndromeEURO CELTIQUE SA·Filed 2014·Granted Nov 14, 2017·1 cites·11 claims
- 1662US9700508B2Pharmaceutical compositions comprising hydromorphone and naloxoneDANAGHER HELEN KATHLEEN·Filed 2011·Granted Jul 11, 2017·1 cites·48 claims
- 1753US10258616B2Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndromeEURO CELTIQUE SA·Filed 2017·Granted Apr 16, 2019·0 cites·18 claims
- 1850US2019224130A1Pharmaceutical compositions comprising hydromorphone and naloxonePURDUE PHARMA·Filed 2018·Application pending·0 cites
- 1950US2015283091A1Pharmaceutical compositions comprising hydromorphone and naloxonePURDUE PHARMA·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →